Carvalho-Silva L, Jiménez-Correa U, Santana-Miranda R, Heyerdahl-Viau I, Benitez-Morales J, García-Casas M, Martínez-Núñez JM. Irrational Use of Medications among Adults with Insomnia: An Observational Study at a Sleep Clinic in Mexico.
PHARMACY 2024;
12:56. [PMID:
38668082 PMCID:
PMC11054186 DOI:
10.3390/pharmacy12020056]
[Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 02/06/2024] [Revised: 03/16/2024] [Accepted: 03/25/2024] [Indexed: 04/29/2024] Open
Abstract
BACKGROUND
To determine the patterns of irrational use of medications among a sample of adult patients with insomnia.
METHODS
We included 89 adult patients diagnosed with chronic insomnia who had consumed medications for this disorder during the 12 months prior to admission to a specialized Sleep Disorders Clinic (SDC) in Mexico City. With a 13-item survey, information was gathered on patterns of medication use and irrational use, considering therapeutic indications, dose, route of administration, and duration of treatment.
RESULTS
The participants had taken hypnotics (65%), antidepressants (21%), anticonvulsants (8%), and antipsychotics (6%), and 92% had irrational use of their medication. Irrational use was greatest with benzodiazepines and antipsychotics. There were two main types of irrational use: (1) 47% of participants had consumed a drug unsuitable for their condition, although it was almost always prescribed by a doctor, and (2) 43% had consumed a drug for longer than the maximum time recommended.
CONCLUSION
It is worrisome to find that the irrational use of medications to treat insomnia, especially benzodiazepines and antipsychotics is widespread. Although most participants had acquired their medication by prescription, for many the drug was inappropriate to treat their condition. It should be mandatory that patients with insomnia receive specialized medical attention in primary clinical care.
Collapse